Upregulation of PRTFDC1 and PODXL2 expression was correlated with poor survival of AML, whereas downregulation of CCNL1 and RP11‐762I7.5 was correlated with poor survival of AML (Appendix Fig S5B). This evidence concerns the gene PRTFDC1 and acute myeloid leukemia.